S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NASDAQ:FSRD

Fast Radius (FSRD) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.0090
$0.0090
50-Day Range
$0.0090
$0.0128
52-Week Range
$0.09
$10.01
Volume
N/A
Average Volume
2.34 million shs
Market Capitalization
$680,742.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
FSRD stock logo

About Fast Radius Stock (NASDAQ:FSRD)

Fast Radius, Inc. operates as a cloud manufacturing and digital supply chain company. The company's Cloud Manufacturing Platform supports engineers, product developers, and supply chain professionals in various stages of product design and manufacturing, including design, make, and fulfill. It offers a range of manufacturing technologies, including additive manufacturing, computer numerically controlled machining, injection molding, sheet metal, urethane casting, and other manufacturing methods. The company was founded in 2015 and is headquartered in Chicago, Illinois. On November 7, 2022, Fast Radius, Inc.,along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

FSRD Stock News Headlines

This is how you fast travel in Starfield
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
FSRDQ Fast Radius, Inc.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Why Is Fast Radius (FSRD) Stock Up 120% Today?
Fast Radius, Inc. Tops Q2 EPS by 1c
Fast Radius Reports Second Quarter 2022 Results
Fast Radius Inc (FSRD)
See More Headlines
Receive FSRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fast Radius and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Fabricated structural metal products
Sub-Industry
N/A
Current Symbol
NASDAQ:FSRD
Fax
N/A
Employees
303
Year Founded
N/A

Profitability

Net Income
$5.95 million
Net Margins
-413.67%
Pretax Margin
-140.63%

Debt

Sales & Book Value

Annual Sales
$4.87 million
Book Value
($0.07) per share

Miscellaneous

Free Float
N/A
Market Cap
$680,742.00
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Lou Rassey (Age 48)
    Co-Founder, CEO & Chairperson
    Comp: $651.1k
  • Mr. Patrick McCusker (Age 44)
    Co-Founder, Pres & Interim CFO
    Comp: $601.1k
  • Mr. John Nanry (Age 37)
    Co-Founder & COO
    Comp: $371.87k
  • Mr. Richard A. Smith
    Co-Founder & Sr. Advisor
  • Dr. William P. King Ph.D. (Age 47)
    Co-Founder & Chief Scientist
  • Mr. James Erkenswick
    Chief Accounting Officer
  • Morgan Scott
    Sr. Director of PR
  • Mr. Brian Simms (Age 41)
    Exec. VP of Sales & Marketing
  • Ms. Heather Baker
    VP of People
  • Mr. Gus Pinto (Age 39)
    Chief Product Officer

This page (NASDAQ:FSRD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners